Local and Lower Limb Complications during and after Femoral Cannulation for Extracorporeal Life Support.


Journal

The Thoracic and cardiovascular surgeon
ISSN: 1439-1902
Titre abrégé: Thorac Cardiovasc Surg
Pays: Germany
ID NLM: 7903387

Informations de publication

Date de publication:
04 2019
Historique:
pubmed: 25 11 2017
medline: 29 5 2019
entrez: 25 11 2017
Statut: ppublish

Résumé

The extracorporeal life support system (ECLS) system is a lifesaving option for patients in pulmonary and/or cardiac failure. We reviewed our data on local complications in the leg and groin during and after ECLS explantation. Patients were included when an ECLS was cannulated in the groin and the ECLS was successfully weaned and explanted. Data were collected retrospectively in patients from January 2013 to January 2016. In this study, 90 patients were included; 39 (43%) ECLS were implanted with surgical cut down and 51 (57%) ECLS were implanted percutaneously. Most patients needed ECLS support following cardiac surgery: cut down: 25 (64%) versus percutaneous: 28 (55%) ( Surgical and percutaneous implantation and explantation of ECLS are safe and feasible with comparable complication rates, including wound healing disorders. We recommend that a lower limb perfusion cannula should be placed to prevent leg ischemia. Surgical cut-down placement of the distal leg perfusion cannula may reduce the incidence of distal leg ischemia compared with percutaneous distal leg cannula implantation. Correct placement of the cannula should be controlled.

Identifiants

pubmed: 29172211
doi: 10.1055/s-0037-1608687
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

176-182

Informations de copyright

Georg Thieme Verlag KG Stuttgart · New York.

Déclaration de conflit d'intérêts

Disclosure The authors report no conflicts of interest in this work.

Auteurs

Maximilian Kreibich (M)

Department of Cardiovascular Surgery, Heart Center Freiburg University, Freiburg, Germany.
Faculty of Medicine, University Freiburg, Freiburg, Germany.

Christoph Benk (C)

Department of Cardiovascular Surgery, Heart Center Freiburg University, Freiburg, Germany.
Faculty of Medicine, University Freiburg, Freiburg, Germany.

Sophie Leitner (S)

Department of Cardiovascular Surgery, Heart Center Freiburg University, Freiburg, Germany.
Faculty of Medicine, University Freiburg, Freiburg, Germany.

Friedhelm Beyersdorf (F)

Department of Cardiovascular Surgery, Heart Center Freiburg University, Freiburg, Germany.
Faculty of Medicine, University Freiburg, Freiburg, Germany.

Julia Morlock (J)

Department of Cardiovascular Surgery, Heart Center Freiburg University, Freiburg, Germany.
Faculty of Medicine, University Freiburg, Freiburg, Germany.

Christian Scherer (C)

Department of Cardiovascular Surgery, Heart Center Freiburg University, Freiburg, Germany.
Faculty of Medicine, University Freiburg, Freiburg, Germany.

Bartosz Rylski (B)

Department of Cardiovascular Surgery, Heart Center Freiburg University, Freiburg, Germany.
Faculty of Medicine, University Freiburg, Freiburg, Germany.

Georg Trummer (G)

Department of Cardiovascular Surgery, Heart Center Freiburg University, Freiburg, Germany.
Faculty of Medicine, University Freiburg, Freiburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH